Literature DB >> 6702623

Reproducibility and treatment of exercise-induced ventricular tachycardia.

A Woelfel, J R Foster, R J Simpson, L S Gettes.   

Abstract

Fourteen patients with exercise-induced ventricular tachycardia (VT) underwent serial treadmill testing, and those with reproducible arrhythmia were treated with a beta-adrenergic blocking agent. In 11 patients (79%), VT of similar rate, morphologic characteristics and duration was reproduced on 2 consecutive treadmill tests performed 1 to 14 days apart. Beta blockade prevented recurrent VT during acute testing in 10 of 11 patients and during chronic therapy in 9. Eight patients had a consistent relation between a critical sinus rate and the onset of VT. In these patients, successful therapy correlated with preventing achievement of the critical sinus rate during maximal exercise. Thus, serial exercise testing is an appropriate means of assessing efficacy of therapy in patients with exercise-induced VT, provided that reproducibility is established on 2 control tests before beginning treatment. Therapy with beta-blocking agents is effective, especially when guided by the presence of a critical sinus rate-VT relation.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6702623     DOI: 10.1016/0002-9149(84)90398-9

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  4 in total

1.  Increased sympathetic nervous system activity as cause of exercise-induced ventricular tachycardia in patients with normal coronary arteries.

Authors:  Ozcan Ozdemir; Mustafa Soylu; Ahmet Duran Demir; Serkan Topaloglu; Omer Alyan; Bilal Geyik; Emine Kutuk
Journal:  Tex Heart Inst J       Date:  2003

2.  Exercise tests and ventricular tachycardia.

Authors:  J Milanes; M Romero; H N Hultgren; U Shettigar
Journal:  West J Med       Date:  1986-10

3.  Effects of beta-adrenergic blockade on verapamil-responsive and verapamil-irresponsive sustained ventricular tachycardias.

Authors:  R J Sung; E C Keung; N X Nguyen; E C Huycke
Journal:  J Clin Invest       Date:  1988-03       Impact factor: 14.808

4.  Arrhythmogenic Right Ventricular Cardiomyopathy - Antiarrhythmic Therapy.

Authors:  Simon Ermakov; Melvin Scheinman
Journal:  Arrhythm Electrophysiol Rev       Date:  2015-08
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.